Press Release

IP Infusion Advances AI Data Center Networking with Ethernet-based Disaggregated Solution

Partners with HYPER SCALERS to Deploy Agile, Cost-Efficient Networks for GPU-intensive AI Workloads.

Santa Clara, CA – July 9, 2025IP Infusion, a global leader in open networking solutions, today announced the release of OcNOS® Data Center (OcNOS-DC) 6.6.1, the industry's most widely deployed disaggregated networking software specifically designed to support the demanding requirements of artificial intelligence (AI) and machine learning (ML) workloads. Built to run on Broadcom's Tomahawk 5 chipset, OcNOS-DC 6.6.1 powers high-performance, low-latency Ethernet-based AI data center fabrics on ONIE-enabled Edgecore AS9817-64D and UfiSpace S9321-64E white-box switches with 51.2Tbps switching capacity.

As AI training clusters scale exponentially, traditional networking solutions struggle to handle the intensive east-west traffic patterns and stringent latency and packet loss requirements of distributed GPU workloads. OcNOS-DC 6.6.1 addresses these challenges with advanced features, including Priority-based Flow Control (PFC) over Layer 3, Enhanced Transmission Selection (ETS), Data Center Bridging Capabilities Exchange Protocol (DCBX), and Dynamic Load Balancing (DLB). These capabilities work cohesively to deliver high-throughput, lossless connectivity, which is critical for AI-driven networks.

OcNOS-DC 6.6.1 enhances AI workload orchestration by exporting real-time gNMI telemetry to orchestrators like Kubernetes, enabling dynamic job allocation and reallocation when network paths are overloaded. Integration with Ansible further automates the reservation of lossless queues, priority-to-traffic-class mapping, and activation of dynamic load balancing on job-specific links, optimizing GPU server rack performance.

By leveraging disaggregated open networking, OcNOS-DC 6.6.1 offers cost-effective scaling, flexibility in optics selection, and agile data center buildouts through competitive bidding and component-level price tracking.

"OcNOS Data Center sets a new standard for AI networking, delivering unparalleled performance and scalability for next-generation data centers," said Kiyo Oishi, CEO of IP Infusion. "By combining Broadcom's Tomahawk 5 chipset with our advanced software features, we're enabling customers like HYPER SCALERS to build agile, cost-efficient networks that meet the rigorous demands of GPU-intensive AI workloads."

"Partnering with IP Infusion to deploy OcNOS-DC 6.6.1 has revolutionized our ability to deliver high-performance GPU-based services," said George Cvetanovski, Founder and CEO of HYPER SCALERS. "The AI-optimized features, seamless orchestration integration, and disaggregated architecture allow us to scale efficiently while maintaining the low-latency, lossless connectivity our customers require for their AI workloads."

Availability

For more information, visit IP Infusion's website or contact ipisales@ipinfusion.com.

Über IP Infusion

IP Infusion develops open network software solutions for carriers, service providers, and data centers. With hundreds of customers and thousands of deployments, IP Infusion leads the market in Network Operating Systems. Its flagship platform, OcNOS®, empowers network operators to disaggregate their networks, streamline operations, and reduce total cost of ownership (TCO). Headquartered in Santa Clara, Calif., IP Infusion is a wholly owned subsidiary of ACCESS CO., LTD. For more information, visit www.ipinfusion.com/

Pressekontakt

Katherine Verducci, 1903 PR
kverducci@1903pr.com
408.429.5779

Über IP Infusion

IP Infusion ist ein führender Anbieter von Open-Networking-Software und liefert OcNOS, ein Carrier-Grade-Netzwerkbetriebssystem für Service Provider, Rechenzentren und AI-Fabric-Netze. Mit 26+ Jahren Netzwerkerfahrung und 600+ Operatoren weltweit ermöglicht IP Infusion offene, herstellerübergreifende, kosteneffiziente und flexible Netzwerkinfrastruktur auf validierter offener Hardware von Partnern wie Edgecore Networks, UfiSpace und Celestica. IP Infusion ist eine hundertprozentige Tochtergesellschaft der ACCESS CO., LTD. (Tokyo Stock Exchange: 4813).

Pressekontakt

For press inquiries, analyst briefings, or media materials, please unser Team kontaktieren or email pr@ipinfusion.com.

Zukunftsgerichtete Aussagen

Diese Mitteilung kann zukunftsgerichtete Aussagen zu Produkten, Technologien und Plänen von IP Infusion enthalten. Zukunftsgerichtete Aussagen beruhen auf den zum Veröffentlichungsdatum verfügbaren Informationen und sind mit Risiken und Unsicherheiten verbunden. Die tatsächlichen Ergebnisse können abweichen. Produktpläne, Funktionen, Release-Termine und Verfügbarkeit können sich ohne Vorankündigung ändern und stellen keine Zusage, kein Versprechen und keine rechtliche Verpflichtung dar. IP Infusion übernimmt keine Verpflichtung, zukunftsgerichtete Aussagen zu aktualisieren.